Biotech stories
Sandy Baker appointed independent non-executive director of Stanchion, brings 30+ years experience in finance, governance and impact investing.
Kaspersky launches comprehensive cybersecurity policy to address the security risks posed by human augmentation technology in the workplace.
2020 will go down in history for the year of the global pandemic, but also for the rise of innovative digital technologies.
Greenpeace's Cool IT Leaderboard highlights IT firms' climate efforts. Cisco leads with 62 points, doubling its score through emissions-saving tech.
With New Zealand aiming to make tech our number two export by 2025, and primary industry already our number one, we need a clear path forward.
New Zealand's biotech industry could boost GDP to $182bn in 12 years, says BiotechNZ executive director Dr Zahra Champion.
NZ shares climbed as the NZX 50 Index rose 0.4%, led by Fonterra's rebound from a record low, while Hallenstein Glassons surged 6.5% on robust profit figures.
